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A B S T R A C T
Schizophrenia and Alzheimer’s disease impacts on various sensory processings are extensively reviewed in the
present publication. This article describes aspects of a research project whose aim is to delineate the neuro-
biology that may underlie Social Withdrawal in Alzheimer’s disease, Schizophrenia and Major Depression. This is
a European-funded IMI 2 project, identiﬁed as PRISM (Psychiatric Ratings using Intermediate Stratiﬁed
Markers). This paper focuses speciﬁcally on the selected electrophysiological paradigms chosen based on a
comprehensive review of all relevant literature and practical constraints. The choice of the electrophysiological
biomarkers were fundamentality based their metrics and capacity to discriminate between populations. The
selected electrophysiological paradigms are resting state EEG, auditory mismatch negativity, auditory and visual
based oddball paradigms, facial emotion processing ERP’s and auditory steady-state response. The primary
objective is to study the eﬀect of social withdrawal on various biomarkers and endophenotypes found altered in
the target populations. This has never been studied in relationship to social withdrawal, an important component
of CNS diseases.
The PRISM project is attempting to identify the underlying neuro-
biological determinants of social withdrawal in selected psychiatric and
neurodegenerative disorders utilizing a very novel transdiagnostic ap-
proach (Insel et al., 2010). Initially the project will focus solely on
Alzheimer’s disease (AD) and schizophrenia (SZ) but ultimately in-
dividuals with major depression (MDD) may also be recruited. The
overarching aim of this project is to further our understanding of the
underlying neurobiology behind these disorders so that subpopulations
could be identiﬁed where personalized medicine approaches may be
amenable. With this somewhat unusual transdiagnostic perspective the
project engaged in a careful review of the possible approaches that
encompassed all these variables. The output of this process is with re-
spect to the electrophysiology and sensory processing work stream is
presented here oﬀering a novel slant on these literatures. For reference,
it is worth noting that phenotypic characterization of schizophrenic,
schizoaﬀective disorders and bipolar disorder patients or their ﬁrst
degree relatives using comprehensive electrophysiological and
behavioral measurements has been conducted previously [please refer
to Ethridge et al. (2015) and Clementz et al. (2016)] and that the
overall quantitative approach is described in greater detail in the other
articles within this special edition (Kas et al., 2017). Essentially, pa-
tients and age-matched healthy controls will undergo quantitative
phenotyping assessment focused on four domains: (1) social withdrawal
(van der Wee et al., 2018); (2) working memory and (3) attention
(Gilmour et al., 2018) and (4) electrophysiological assessments of
sensory processing (described in this article and Hornix et al., 2018).
Social withdrawal will also be stratiﬁed according to a reference clinical
scale (WODAS II) with cutoﬀs deﬁning low and high withdrawal. This
use of stratiﬁcation allows the impact of these independent factors, on
multiple quantitative measures, to be assessed and hence provide en-
hanced statistical sensitivity. This will allow the apparent similarities
between populations, which may be based on very diﬀerent constructs,
to be disentangled.
The negative symptoms and cognitive impairment in schizophrenia
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have been demonstrated to be independent components of schizo-
phrenia (Bilder et al., 2000; Hughes et al., 2003; White et al., 1997).
However social withdrawal, an important element of quality of life and
a consequence of schizophrenia, is hypothetically related to negative
symptoms and to the other dysfunctional processes, including sensory
processing (Haigh et al., 2016). The question of what is the biological
ground of social withdrawal is the main question that PRISM will
analyse across the diﬀerent domains, in Schizophrenia but also in other
populations with negative symptoms and social withdrawal : Alzhei-
mer’s disease (Reichman et al., 1996; Reichman and Negron, 2001) and
Major Depression (Galynker et al., 2000; Gerbaldo et al., 1995; Kulhara
and Chadda, 1987). Processing of sensory modalities, predominately
auditory and visual have been shown to be repeatedly altered in pa-
tients with AD and SZ (see Table 1). Morever, olfactory impairment has
also been reported in both pathologies (Albers et al., 2015; Moberg
et al., 2014; Zou et al., 2018). As a variety of approaches have been
used to probe the diﬀerent constructs of sensory processing, a com-
prehensive and detailed literature review was conducted to identify the
most appropriate methodology for robust and consistent assessments.
The key criteria employed for task selection were methodological
standardization, test-retest reliability and discriminative sensitivity
between disease pathologies and age eﬀects. The later was considered
important as the patient populations that will be recruited span a broad
age range and it is well known that sensory capabilities are impacted
with age (Musiek et al., 2005; Schadow et al., 2007).
Finally, it is important that the identiﬁed tasks are considered for
their back-translational capabilities to facilitate inter-species assess-
ments. For example, using geometric shapes in the visual oddball task
rather than pictures would facilitate future assessment in non-human
primates and potentially in rodents. It is important to note that an ex-
ception is made for the emotional processing task which although well
established for functional magnetic resonance imaging (fMRI), is con-
siderably less in its EEG modality and thus is identiﬁed as an ex-
ploratory endpoint only (Sfärlea et al., 2016). Finally, due to the limited
amount of test time the patients may tolerate per session, during the
electrophysiological, fMRI and behavioral testing, choices were made
based on the intrinsic value of each task versus the time spent required
to execute them. The selected electrophysiological tests are resting state
EEG, auditory mismatch negativity, auditory and visual based oddball
paradigms, facial emotion processing ERP’s and auditory steady-state
response. The selected tests, end points and key references are high-
lighted in Table 1. In order to verify that the parameters of each test
were optimal, they (except FERT) were tested in healthy subjects in
order to verify that outcome similar to the reference publications (in-
dicated in the text) can be obtained. Two test populations were used for
validation (Biotrial data on ﬁle): 124 recordings at baseline of a cross-
over study conducted in 35 healthy male subjects aged 22–46 years
(population A) and 21 healthy subjects (9 males and 12 females), aged
24–48 years and recruited later (population B). All were healthy and
drug- free. The PRISM study itself is well on its way and is assessing
quantitative biomarkers in schizophrenia (N=72 SZ), Alzheimer’s
Disease (N=72 AD) comparatively to healthy matched controls
(N= 48).They will complete a series of fMRI, EEG, and behavioural
paradigms, as well as contributing blood-derived (e.g. epigenetic) and a
smartphone application collecting data related to social behavior (see
Bilderebeck et al., 2018).
1. Objectives
These diﬀerent dimensions used in phenotyping will be used in a
multidimensional analysis using social withdrawal as a main grouping
factor and analyze the links with the other dimensions with no under-
lying statistical hypothesis. For this purpose, the population is com-
posed of half of patients with a high withdrawal level on a subscore of
the World Health Organisation Disability Assessment Schedule
(WHODAS-II) (Von Korﬀ et al., 2008) and half with a low withdrawal
level, with no overlap. In the present manuscript we will put forward
the EEG endpoints of resting brain and several Evoked Related Poten-
tials during Mismatch Negativity, Auditory and visual oddball para-
digms and Facial emotion Processing as well as Auditory Steady State
response to repeated stimuli.
2. Selected methods
2.1. Resting state EEG
The underlying neuronal circuitry involved in generating neuronal
oscillations recorded by EEG are complex and diverse. All excitable
membranes within the vicinity of the EEG electrodes, contribute at least
in some part to the extracellular ﬁeld potential recorded (Malmivuo,
2012). The electrical generators, from the very fast action potentials at
the soma, axon or axonal terminals to the synaptic excitatory and in-
hibitory events associated with dendrites, superimpose at any given
moment to elicit the recorded electrical potentials. Synchronized ac-
tivity within or between any of these generators results in a measurable
signal at the level of the EEG. The degree to which synchronization
occurs at speciﬁc neuronal oscillation frequency bands is highly de-
pendent on sensory input (for example, eyes open or closed), arousal
levels (sleep versus awake) and cognitive load. To assist in classifying
changes in these speciﬁc oscillations, frequency band deﬁnitions were
deﬁned (slow waves, delta, theta, alpha, beta and gamma; Jobert et al.,
2012). These boundaries although based on prominent peaks in the
power spectrum that occur during speciﬁc behaviors and in speciﬁc
brain areas, are not often generalizable but do provide a somewhat
robust framework from which to base comparative studies.
It is important to note that the EEG oscillations are inherently
changeable, the most prominent is the classical alpha rhythm ﬁrst de-
scribed by Hans Berger (Berger, 1929) and originally termed Berger’s
wave. The alpha wave slowly oscillates when subjects have their eyes
closed and are in a state of relaxed wakefulness, but it is immediately
substituted with a faster and lower amplitude beta/gamma wave when
eyes are opened. This is important to note as it highlights the critical
importance of controlling a subject’s behavioral state during EEG col-
lection but also highlights that the non-stationary component of oscil-
latory amplitude, power and cross cortical synchrony also needs to be
considered when collecting and analyzing data.
The most commonly reported changes in resting state EEG found in
AD patients is a generalized EEG slowing. In both AD and Mild
Cognitive Impairment (MCI) patients, the slowing is typically observed
as a decrease in the mean frequency, alpha and beta band power with a
corresponding increase in delta and theta band power when compared
to healthy elderly (Bhattacharya et al., 2011; Jelic et al., 2000; Jelles
et al., 2008; Jeong, 2004; Koenig et al., 2005; Park et al., 2008). In-
triguingly, the increase in theta and delta band activity during wake
contrasts with a reduction in slow wave activity that is observed during
sleep in AD patients (Hassainia et al., 1997). One interpretation of this
observation is that the disruption of the intrinsic circadian rhythms or
sleep continuity leads to an abnormal increase in delta waves in awake
AD patients, thus leading to a reduction during slow wave sleep. Others
have argued that the enhanced slow wave and theta activity observed
during wakefulness is a direct result of the cholinergic and/or other
neurotransmitters deﬁcits associated with AD (Adler et al., 2009;
Babiloni et al., 2011). This hypothesis is also supported by studies
showing that the acetylcholinesterase inhibitor rivastigmine in AD pa-
tients decreases power in both the delta and theta frequency bands and
increases lower alpha frequency band power in those that show cog-
nitive improvements (Gianotti et al., 2008). Moreover, muscarinic an-
tagonists such as atropine and scopolamine have also been shown to
produce a slowing like EEG phenotype in both cats and humans.
The circuits responsible for the generation of slow and delta EEG
waves have been well described (Crunelli and Hughes, 2010; Destexhe
et al., 2010) resulting from both the intrinsic bi-stability of cortico-
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cortical synaptic neuronal networks (Steriade and Amzica, 1996) and
the interplay with intrinsic oscillators within the thalamus (Crunelli and
Hughes, 2010; Destexhe et al., 2010). The slow wave oscillations can be
both large global network states as in deep slow wave sleep or more
localized in speciﬁc cortical networks (Onisawa et al., 2017). It is
therefore somewhat counter intuitive that slow wave power so depen-
dent on synaptic connectivity is enhanced in a disease condition asso-
ciated with such profound synaptic and neuronal loss (Busche et al.,
2015). Thus, changes in neurotransmitter, hypometabolism (Babiloni
et al., 2016a) may be involved as well as the reduction of activity of
other generators like alpha which seems to correlate with hippocampus
atrophy (Babiloni et al., 2009).
In contrast to AD, the commonly reported changes in the EEG signal
observed in SZ patients are alterations in higher frequency bands (beta
and gamma), but most notably task-evoked changes rather than resting
state changes are usually reported more often. However, there are re-
ports of changes in gamma oscillations in SZ patients either at rest or
preceding a speciﬁc task. There is also evidence to suggest that the
pattern of spontaneously occurring gamma-band activity may diﬀer
from the neural oscillations associated with cognitive processing. For
example, Kikuchi and colleagues examined resting-state EEG-data in
medication naïve, ﬁrst-episode SZ patients versus healthy controls and
found signiﬁcantly elevated gamma-band power over the frontal elec-
trode areas (Kikuchi et al., 2011). Interestingly, these changes were not
seen in chronic SZ patients (Rutter et al., 2009). The interpretation and
comparability of these ﬁndings is complicated by the fact that it is
currently unclear whether the generating mechanisms underlying the
high-frequency activity during rest are comparable to those seen during
task-related oscillations. Classical gamma band oscillations emerge
from the interactions of pyramidal cell excitation and inhibition from
parvalbumin positive spiking interneurons within cortical networks
(Buzsáki and Wang, 2012). These would however be expected to pro-
duce a clear and deﬁned peak in the fast Fourier transform spectrum
that can be seen during speciﬁc tasks and brain areas. In contrast,
broadband power changes in the higher frequency bands are more
likely explained by the sum of local synaptic events and action poten-
tials and hence just the level of local cortical activation (Uhlhaas, 2011)
rather than a speciﬁc oscillatory generator.
For the PRISM studies, EEG will be recorded in resting conditions
with two sessions with eyes closed (5min per session) separated by one
5-min session with eyes open. Both test conditions are required as
spectral diﬀerences between AD and healthy controls are frequently
seen in an eyes closed condition, but not in eyes open condition
(Tartaglione et al., 2012). The comparison of spectral content (alpha
band power) with eyes closed versus eyes open should discriminate
between patients with SZ and healthy controls (Zaytseva et al., 2014).
The power spectrum per electrode across 59 channels will be estimated
and summarized using the reference International Pharmaco EEG So-
ciety (IPEG) frequency bands (Jobert et al., 2012), with delta:
[1.5–6 Hz], theta [6–8.5 Hz], alpha 1 [8.5–10.5 Hz], alpha 2
[10.5–12.5 Hz], beta 1 [12.5–18.5 Hz], beta 2 [18.5–21 Hz], beta 3
[21–30 Hz] and gamma [30–40 Hz]. The area under the curve (AUC) of
spectra segments will provide an estimation of power in each frequency
band of interest. Absolute and relative powers will be analyzed for each
band, both in eyes open and eyes closed conditions. For each band, the
relative power will be the absolute power divided by the power on the
total band.
With respect to data quality control, under both test conditions, all
recordings will be visually inspected to reject artifact segments such as
high frequency noise caused muscular activity, environmental noise, or
eye blinks. In case of sleep episodes occurring during the recording
period, these will be manually rejected from the analysis. The artifact
free signal from each electrode will then be analyzed using a fast
Fourier transform (FFT) to produce a power spectra. EEG ﬂat maps will
be created using absolute and relative powers estimated following IPEG
deﬁnitions for frequency bands. To study resting brain circuitries,
several electrode signals will be used simultaneously and additional
computations will be conducted to assess potential relationships within
or between speciﬁc brain regions. The correlations between an elec-
trode and its neighbor (local properties) will be used with the cordance,
that will ultimately provide data comparable with that obtained with
brain imaging (Bell et al., 2012; Leuchter et al., 1994).
Connectivity at the scalp level can be quantiﬁed by several methods
(Sakkalis et al., 2011), with coherence (Pascual-Marqui et al., 2014) as
one of the most characterized thus permitting synchronization (Tan
et al., 2013) or coupling quantiﬁcation between electrodes (Babiloni
et al., 2016b). Additional eﬀorts derived at determining the cortical
sources underlying the activities observed on the scalp (source locali-
zation) may also be implemented. Since the 1990’s, low resolution
brain electromagnetic tomography (Loreta) is widely used to estimate
sources (Babiloni et al., 2011; Pascual-Marqui et al., 1994) which can
also be the ﬁrst step toward more complex methods targeting resting
state networks (Aoki et al., 2015; Olbrich et al., 2014).
2.2. Auditory mismatch negativity
Mismatch Negativity (MMN) is passively evoked when a sequence of
repetitive standard stimuli is occasionally interrupted by infrequent
oddball or deviant stimuli that diﬀer in some physical dimension (pitch,
duration). The onset of MMN occurs within 50ms of stimulus deviance
and peaks after an additional 100–150ms. MMN is thought to result
from pre-attentive processes, since it is present when a subject is in-
volved in tasks that are unrelated to a MMN stimuli (Garrido et al.,
2009) and may even be modulated by attentional processing (Arnott
and Alain, 2002). Two major hypotheses have been proposed to explain
MMN, which can be uniﬁed within a predictive coding framework
(Garrido et al., 2009). First, within the adaptation hypothesis
(Jääskeläinen et al., 1999), the N1 response is modulated by similarities
between the common tones and the novel tone and thus the MMN is
generated locally at the auditory cortices. Second, within the model
adjustment hypothesis (Näätänen et al., 2007), the incoming regular
stimuli form a memory trace and the MMN is originated from circuitry
comparing the novel stimuli with an internal representation. The inter
stimulus intervals (ISI’s) for which a MMN is elicited have been com-
monly associated as indicative measures of a memory trace duration.
This is typically around 10 s for healthy young adults (Sams et al.,
1993) and no more than 4.5 s in healthy older subjects (Pekkonen et al.,
1996).
Both temporal and frontal circuitry have been identiﬁed underlying
MMN. Although bilateral activation of the auditory cortices is known to
be a primary contributor (Duncan et al., 2009), frontal components
have also been described using EEG, MEG and fMRI (Fulham et al.,
2014). Rinne et al. discovered that the frontal component of the MMN
peaked later than the temporal component, lending support for the
existence of a temporo-frontal network underlying MMN (Rinne et al.,
2000). At the molecular level, the NMDA receptor has proven to be
crucial for MMN in several cross-species studies and further support for
this was generated when the NMDA receptor antagonist ketamine was
shown to trigger a reduction in MMN amplitude in both the temporal
and frontal generators in humans (Heekeren et al., 2008). Modulations
of dopaminergic, GABAergic, serotonergic pathways have also been
reported to alter the MMN response, although with less consistent ef-
fects (Garrido et al., 2009).
AD patients have been shown to present with a shorter MMN ISI
from modulation, hypothesized to represent the memory trace, than
their age-matched controls, whilst their MMN amplitudes in response to
frequency deviants was found not to be altered at short ISIs of around
1 s, but decreased amplitudes were found for longer ISIs of 3 s
(Pekkonen, 2000). In SZ patients, reduced MMN amplitude is a con-
sistent ﬁnding for a wide range of ISI’s (0.99 standard eﬀect size across
32 studies with ISI’s ranging from 0.25 to 4 s) (Umbricht and Krljes,
2005) and was found to correlate with global functional scores (Fulham
P. Danjou et al. Neuroscience and Biobehavioral Reviews 97 (2019) 70–84
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et al., 2014; Light and Braﬀ, 2005). Duration deviants have been shown
to be more sensitive than pitch deviants in SZ in MMN meta-analyses.
Haigh et al. (2017) found no evidence of pitch MMN alteration in ﬁrst
episode SZ patients and whereas others authors (Umbricht et al., 2006)
found stronger eﬀects with changes in duration than pitch. At the early
stages of AD, pitch deviants have shown little sensitivity while duration
deviants elicit a more profound response (Pekkonen, 2000). Moreover,
mimicking the cholinergic deﬁcit of AD with scopolamine conversely
produces a greater response on pitch deviants (Pekkonen et al., 2001).
The methodology that will be used in PRISM for MMN induction,
recording and analyses will adhere to the guidelines derived from
Duncan and colleagues (Duncan et al., 2009). Essentially, auditory
MMN will be recorded in two test conditions: eyes closed and eyes
open. Each test will last 6 min in the eyes closed condition and 12min
in the eyes open condition. The inter-stimuli interval will be 600ms.
For the eyes closed condition, subjects will be asked to keep their eyes
closed and detract their attention from the sound. They will be ran-
domly presented a series of two tones: frequent (85% probability) with
standard tones (1000 Hz, 50ms) and one infrequent (15%) pitch de-
viant tone (1100 Hz, 50ms). All tones will have a 5ms rise and fall time
and will be played using headphones at 85 dB level. A total of 600 tones
will be presented, with a total of 90 deviant and 510 frequent tones. For
the eyes open condition, subjects will be asked to watch a short silent
video to provide a visual distraction whilst a series of tones with
identical properties as those used in the eyes closed test will be ran-
domly presented. A total of 1500 tones will be played with 120 pitch
deviants, 120 duration deviants (1000 Hz @ 100ms) and 1260 frequent
tones. The intensity of sounds used are similar to the one used by others
authors (Chang et al., 2014a,b; Light et al., 2015).
Triggers synchronized with tone emission will be recorded on a
channel of the EEG acquisition system. Artefact rejection will be con-
ducted using an automatic rejection routine when EOG exceeds 75 μV
within [−200; +1000ms from the trigger] using Scan4.5
(Compumedics/neuroscan, Charlotte, USA) and then by exclusion of
noisy segment performed visually by a trained technician. Then
Mathlab will be used to perform the few tasks Scan4.5 cannot execute
with a personal library or FieldTrip to estimate time-frequency re-
presentations and to generate ﬁgures. After the rejection process, re-
sponses to the frequent and rare sounds will be averaged. For each
electrode, the average response will be deﬁned by considering the
diﬀerence between the average ERP induced by the frequent stimuli
and the average ERP induced by the deviant stimuli. The parameters of
interest will be the morphological descriptors of the wave of interest:
amplitude, latency and area or average amplitude.
It is clear that MMN is altered in SZ and AD although the ISI impacts
the degree of impairment in AD. Typically, longer intervals are required
(greater than 1–1.5 s) to discriminate AD patients from controls
(Pekkonen, 2000). In the planned studies, if these test parameters are
not suﬃcient to discriminate between the two patient populations,
additional analyses such as source localization performed with LORETA
will ﬁrst be used on the regions of interest, namely the auditory and
prefrontal cortices. Complementary modelling methods such as dy-
namic causal modelling or functional connectivity can then be selected
based on the regions of interest on the basis of an understanding of the
network (Fulham et al., 2014; Garrido et al., 2009; Hughes and Rowe,
2013).
Preliminary data derived from twenty-one healthy subjects the
MMN response produced similar patterns and amplitudes to that ob-
served in the published literature (Duncan et al., 2009; Fulham et al.,
2014; Todd et al., 2008).
2.3. Auditory oddball
The auditory oddball task is a commonly used paradigm that re-
liably produces a speciﬁc event-related potential across the parieto-
central area of the skull that usually occurs around 300ms after stimuli
presentation termed the P300. The P300 is commonly interpreted
within a context updating model (Polich, 2007). According to this
model, incoming stimuli, such as tones are compared with a memory
trace of the previously presented stimuli. If the novel stimulus matches
this memory trace, sensory potentials such as N100, P200, N200 are
evoked. If the stimulus is diﬀerent, attentional processes are also en-
gaged and the memory representation is updated. In line with this
model, the P300 amplitude increases as the probability of deviant oc-
currence decreases (Polich, 1987). Additionally, the P300 latency is
thought to reﬂect classiﬁcation speed (Polich, 2007), as shorter P300
latencies are associated with higher cognitive performance in healthy
subjects (Polich et al., 1983; Polich and Martin, 1992), and with in-
creased memory function in the ageing population (Braverman and
Blum, 2003).
The P300 latency has been repeatedly shown to increase from
healthy controls to MCI and from MCI to AD (Howe et al., 2014). This
increased P300 latency in AD-pathology is accompanied by a decreased
amplitude (Hedges et al., 2016). P300 abnormalities have also been
characterised in SZ across several studies. For example, Bramon et al.
(2004) conducted a meta-analysis from forty-six auditory oddball stu-
dies in SZ and concluded that there is a decreased P300 amplitude and
an increased latency with standardized eﬀect sizes of 0.85 and 0.57,
respectively (Bramon et al., 2004). Interestingly, the P300 amplitude
seems to be related in SZ to verbal learning and memory capability
(Kim et al., 2003).
The P300 can be recorded intracranially from widespread cortical
and subcortical areas of the brain, including the frontal, parietal and
occipital lobes, the thalamus and the hippocampus (Soltani and Knight,
2000). It can also be recorded via EEG at broad areas of the scalp, but it
is strongest at the midline electrodes (Polich, 2007). Although the P300
has been hypothesized to arise from network activity (Duncan et al.,
2009), lesions studies have described where the most important nodes
for P300 generation are located. Whilst the P300 is conserved or
minimally aﬀected by a variety of cortical and subcortical lesions
(Duncan et al., 2009), lesions in the temporo-parietal region dramati-
cally impact the P300 potential (Knight et al., 1989; Kutas et al., 1990).
From a neurochemical perspective, the glutamatergic system is thought
to play a key role in the P300 wave (Frodl-Bauch et al., 1999) and
pharmacological studies have shown that ketamine elicits a reduction
of the P300 amplitude (Oranje et al., 2000). The GABAergic and cho-
linergic systems are also considered to have important contribution to
the P300. Whilst acetylcholine increases the P300 amplitude and de-
creases its latency, GABA elicits the opposite eﬀect (Soltani and Knight,
2000). The noradrenergic, dopaminergic (Huang et al., 2015) and ser-
otonergic systems have also been shown to modulate P300, possibly
indirectly by inﬂuencing the GABAergic and cholinergic systems
(Soltani and Knight, 2000).
In the planned studies, the P300 wave will be assessed in response
to an auditory oddball stimulus. Subjects with eyes closed will be asked
to count the rare, high-pitched sounds (15% of the presentations @
2000 Hz) that will be presented amongst the more frequent sounds
(85%) using a lower frequency (500 Hz) tones. The interval ISI will
randomly vary from 1200 to 1900ms. The number of rare tones will be
randomly determined but lie between 30 and 40. The volume for each
stimulus will be 85 dB and they will each be 100ms in duration. All
stimuli will have a rise and fall times of 10ms and the task will take
between 4 to 9min dependent of the number of rare tones and ISI. The
participant will be asked at the end of the session how many tones were
presented.
The P300 wave form will be quantiﬁed by its latency (duration
between the stimulus onset and most positive peak within a
260–480ms window), its amplitude (amplitude of the most positive
peak within the 260–480ms window) and its average amplitude at the
232–352ms window. All parameters will be estimated using epochs
related to rare sounds only. The epochs amplitudes will be corrected by
subtraction of the average value from the pre-stimulus period (average
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amplitude on the [−500; 0ms] window). Artefact rejection: epochs
with a signal amplitude exceeding 75μV within 500ms to +500ms of
the trigger will be rejected from the averaging process. Time frequency
representations of the ERP will also be analysed: evoked power, in-
duced power and phase locking factor. The power will be averaged on
the relevant epochs. As auditory and visual P300 have a very diﬀerent
time and circuit properties, they will be analysed separately (Katayama
and Polich, 1999). The localisation of sources for P3a and P3b will be
analysed using LORETA (Bachiller et al., 2015) as well as connectivity
(Fujimoto et al., 2013). Auditory P300 previously obtained on a large
database (n= 124) produced the expected pattern latency and mag-
nitude.
2.4. Visual oddball
Visual oddball paradigms elicit both sensory processing and cogni-
tive responses. The brain areas with activations over numerous repeats
per acquisition were initially located using fMRI studies and found to be
present in the supra-marginal gyrus, anterior cingulate cortex (Clark
et al., 2000; Kiehl and Liddle, 2001), thalamus, insula (Clark et al.,
2000; Linden, 2005), dorsolateral prefrontal cortex and medial frontal
gyrus (Clark et al., 2000; Kiehl and Liddle, 2001; McCarthy et al., 1997;
Yoshiura et al., 1999) as well as other cortical areas (Ardekani et al.,
2002). Working memory contribution in the novel stimulus processing
of the visual P300 is related to the frontal, parietal, inferior temporal
areas and the insula (Bledowski et al., 2004). A reduced P300 ampli-
tude has been localised to posterior and occipital areas (Oribe et al.,
2013). The reduction in P300 amplitude has been shown to be a pro-
gressive decline throughout one year in SZ patients (Oribe et al., 2015).
Reduced amplitudes were also observed in ﬁrst episode SZ patients
together with delayed P300 and N1 latencies. Furthermore, prodromal
schizophrenics elicit a characteristic P300 deﬁcit with amplitude re-
ductions associated with increased severity of positive symptoms (Oribe
et al., 2013). It is perhaps unsurprising that reduced P300 amplitudes
are found in SZ, as volumetric abnormalities have been observed in the
cortical grey matter of critical brain structures such as the frontal,
temporal and parietal lobes as well as the left Heschl’s gyrus (Kasai
et al., 2003; Vita et al., 2012).
Over the course of AD, the P300 generators shift from frontal and
occipital regions to be more located in the temporal lobe (Papadaniil
et al., 2016). A reduction in frontal P300 amplitude was observed in
MCI patients (Yener et al., 2014) and advanced AD patients have been
shown to elicit reduced frontal theta (Caravaglios et al., 2010) as well
as reduced frontal, parietal and central delta power (Caravaglios et al.,
2008; Yener et al., 2008). Evidence also exists that cholinergic drugs
modulate these responses with treated AD patients having similar phase
locking and frontal theta power as healthy elderly controls (Yener et al.,
2007). This highlights that cholinergic modulation of the cognitive
processes contribute to the visual P300.
The P300 wave will be assessed in response to a visual oddball
stimulus (circular line) presented randomly amongst another more
frequent visual stimulus (square). The number of oddball stimuli will be
randomly determined, but will lie between 25–30. All subjects will be
asked to count the number of presented oddball stimuli during the task.
ISI’s will vary randomly from 1600 to 2100ms and stimulus duration
will be 100ms. Stimulus intensity (85 dB) will be similar to Light et al.
(2015). The task will take up to six minutes to complete. The P300 wave
will be quantiﬁed by its latency (duration between stimulus onset and
most positive peak within the 260–480ms window), its amplitude
(amplitude of the most positive peak within the 260–480ms window)
and its average amplitude in the 320–430ms window. The window at
which the average amplitude is estimated occurs later than the one
employed for the auditory P300 as the visual P300 emerges later and
has been well described (Bennington and Polich, 1999; Duncan et al.,
2009).
All parameters will be estimated using epochs related to the rare
visual presentations and epochs amplitudes will be corrected by sub-
traction of the average value from the pre-stimulus period (average
amplitude of the −500 to −0ms windows). Epochs with a signal
amplitude exceeding 75μV within −500ms to +500ms of the trigger
will be rejected from the averaging process. The analysis processing
used for the auditory P300 data can also be used in the visual P300 task,
but there may be a need to take into consideration the extended latency
of the P300 peak (Biotrial data on ﬁle) and therefore the diﬀerent time
windows of interest to quantify P300 occurrence. As expected, the
highest P300 amplitude is observed in centro-parietal area of the ﬂat
map. This area matches the region of interest commonly used to study
P300 (Oribe et al., 2015).
2.5. Auditory steady state response
The ASSR is used to assess the capacity of auditory pathways to
generate synchronous oscillations and the integrity of these pathways at
given frequencies of an auditory stimulus. The source of the ASSR has
been localised in the primary auditory cortex both in human (Herdman
et al., 2002; Pantev et al., 1996) and animal (Conti et al., 1999; Dolphin
and Mountain, 1992) studies. In contrast to amplitude modulated ASSR
stimuli, click stimuli activate greater areas of the primary auditory
cortex leading to higher amplitudes (O’Donnell et al., 2013b). The lo-
calisation of contributing brain structures is frequency speciﬁc. High
synchronous oscillations elicited by frequencies modulated above 80 Hz
are generated solely by the brainstem (Herdman et al., 2002) but fre-
quencies in the low gamma range (30–40 Hz) also have components
generated by the primary auditory cortex (Pantev et al., 1996).
Phase synchronicity of generated ERP’s from a 40 Hz stimulus has
been observed to be delayed in onset with delayed desynchronization in
patients diagnosed with SZ (Hong et al., 2004). This appears unrelated
to pharmacological treatment as these ﬁndings have been replicated in
patients during ﬁrst episodes (Spencer et al., 2008) and in ﬁrst degree
relatives (Rass et al., 2012). Phase locking of the ASSR is reduced in SZ
in comparison to healthy controls for a 40 Hz frequency modulation
whereas no diﬀerences were observed for 20 or 30 Hz frequency
modulations (Hirano et al., 2015). There is some debate as to whether
ASSR deﬁcits are related to the presence of auditory hallucinations
(Hirano et al., 2015; O’Donnell et al., 2013b) or not (Griskova-Bulanova
et al., 2016). Observed ASSR SZ related deﬁcits in frequency processing
are likely to relate to the reduction in grey matter volume of the su-
perior temporal gyrus where the auditory cortex is situated. Post-
mortem tissue analysis of SZ patients has conﬁrmed the reduction of
temporal pyramidal neurons in the primary and secondary auditory
cortices (Sweet et al., 2003). Furthermore, abnormalities in parval-
bumin-expressing basket cells have also been proposed as source for the
altered gamma oscillations observed in SZ (Lewis et al., 2012; Sohal
et al., 2009).
Agonists for the GABAergic system have been observed to attenuate
the 40 Hz ASSR indicating a role for GABA in auditory processing
(Jääskeläinen et al., 1999; Plourde et al., 2008). Reduced amplitude
ASSRs have also been associated with an upregulation of GABA, char-
acteristic of SZ (Brambilla et al., 2003; Deng and Huang, 2006). The
inﬂuence of GABA on the ASSR is a component in the reduction of
phase locking (Griskova-Bulanova et al., 2013) and the decreasing
synchronisation of high gamma with advancing age (Goossens et al.,
2016). In contrast to healthy aging, AD is associated with enhanced
ASSR in the low gamma range (Di Lazzaro et al., 2004; Osipova et al.,
2006; van Deursen et al., 2011) and this is attributed to disinhibition of
the GABAergic system (Limon et al., 2012). The changes measured in
advanced AD patients appears to be related to temporal lobe neuro-
degeneration as the auditory processing deﬁcit does not appear to be
present at earlier stages of the illness when the temporal lobe is func-
tional and largely unaﬀected (Villeneuve et al., 2017).
For the PRISM studies, EEG activity in the gamma range will be
assessed in response to auditory oddball stimuli. Subjects will be asked
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to ﬁxate on a point on the monitor and asked to count the number of
rare tones (10% @ 1000 Hz) that will be presented amongst more fre-
quent stimuli (90% @ 1000 Hz modulated by a 40 Hz sinusoid). As we
usually generate ASSR using clicks and as amplitude modulation was
used instead, in order to limit hearing issues in the elderly the eﬃcacy
of this type of sound to generate ASSR was ﬁrst veriﬁed in population B
(Biotrial data on ﬁle). A total of 110 tones were presented, each tone
lasting 2 s (Tan et al., 2015). The ISI varied randomly from 3.3 to 3.7 s
with the sound level of each stimulus set at 78 dB. The duration of this
task is approximately 7min.
Artefact rejection will be performed by rejecting epochs for which
the signal amplitude exceeds 75μV within the −500 to+2000ms of
the trigger. By using this period, the time course of both the evoked and
induced power in the gamma band will be estimated on a 35–45 Hz
band of interest between a −450 to 1950ms period. The evoked or
induced power will be averaged on a 500–1950ms period. The 1000 Hz
carrier modulated at 40 Hz elicits a robust response in gamma band in
healthy subjects (Biotrial data on ﬁle). Evoked gamma is more pro-
nounced using click presentations rather than a modulated 1KHz si-
nusoid. As the clinical population under test will also contain elderly
individuals, where hearing loss across high frequencies are common, it
is preferred to use narrow spectrum sounds. ASSR will be analysed as
inter-trial coherence per hemisphere with a source modelling approach
according to a robust model previously developed (Edgar et al., 2017).
2.6. Facial emotions processing
Social cognition and social functioning are impaired in SZ (Barkhof
et al., 2015; Langdon et al., 2014) and in AD (Belfort et al., 2017; Bora
and Yener, 2017). These functions will be probed by the Facial Emotion
Recognition Task that will be used with fMRI and repeated with EEG
and recording ERPs on a separate session (see Table 2). At the end, the
spatial resolution of fMRI and the time resolution of ERPs will be both
used in the global analysis.
The networks involved in emotional processing include the amyg-
dala, hypothalamus, meso-corticolimbic dopaminergic system, orbito-
frontal, dorsolateral prefrontal and temporal cortices and parts of the
parietal cortex (Adolphs et al., 1996; Breiter et al., 1996; LeDoux, 1995;
Sprengelmeyer et al., 1998). From observations derived from CNS le-
sions, PET and functional MRI studies that have focused on the spatial
dimension of the response, the temporal properties of the ERP’s have
been deﬁned. An early and automatic processing stage (P100), corre-
sponding to a perceptive stage peaks at the occipital electrodes and is
modulated by attentional processing (Luck et al., 2000). This is closely
followed by a vertex positive occiput-negative ERP component (N170)
that corresponds to the structural encoding of the face (Eimer, 2000).
The magnitude of this wave is increased with emotional faces when
compared to neutral faces (Batty and Taylor, 2003; Holmes et al., 2008;
Rellecke et al., 2012) and appears to involve the middle fusiform gyrus
(Haxby et al., 2000).
Modulation of the magnitude of N170 has been replicated (Munk
et al., 2016) and the later potentials involved in the aﬀect recognition
have also been reliably reproduced (Herbert et al., 2008; Rellecke et al.,
2012; Schupp et al., 2006). The 200–300ms domain represents a se-
lective attentional surge (Schupp et al., 2006) and is associated with
increased visual attention. Its maximal response occurs in temporo-
occipital regions and is more pronounced for emotionally valenced
faces either negatively or positively. The ﬁnal component is the late
posterior potential (LPP) which occurs under the centro-parietal elec-
trodes around 300ms from stimulus onset and corresponds to the later
processing stages of emotionally salient material: stimulus representa-
tion in working memory and late cognitive emotional processing
(Rellecke et al., 2012). Similar to the early posterior negativity (EPN),
LPP waves are enhanced by valence stimuli and show a greater en-
hancement for fear, suggesting a two-step processing for facilitation and
processing. A network analysis by MEG shows a right prefrontal cortex
bottom-up and a top-down coupling bilateral to occipito-parietal cor-
tices (Moradi et al., 2017; Moratti et al., 2011).
The face stimuli, provided by P1Vital (UK), comprises of one hun-
dred and sixty coloured photographs with the faces of 40 diﬀerent in-
dividuals (20 female and 20 male) displaying four expressions (neutral,
happy, sad and afraid). A mask with an ellipsoid aperture is applied to
all stimuli, so that only the facial areas are visibleand all stimuli are
presented on the center of the screen on a black background. Each face
stimuli will be presented twice. Subjects will be placed at a ﬁxed po-
sition from the screen (150 cm) and instructed to direct their eyes and
attention towards the computer screen to avoid movements and blinks
during the task and to give answers as accurately and quickly as pos-
sible. During the test session, lasting approximately 15min, each sub-
ject will view a total of 320 photographs and will have to decide if the
person on each photograph is a male or a female by pressing on a re-
levant (left or right) button from a pad. Each trial will proceed in the
following sequence: a ﬁxation cross on a black background presented
for a variable interval from 800 to 1200ms, a face stimulus presented
during 1500ms and a black screen for 1000ms. Answers given during
the stimulus presentation or during the black screen will be recorded.
Subjects will be presented a total of 320 trials, with 80 trials of each
emotional face category. The order in which the faces will be presented
will be pseudo randomly assigned.
The ERP time windows and ROI’s were selected based on prior
studies using emotional face stimuli (Batty and Taylor, 2003; Rellecke
et al., 2013, 2012; Schupp et al., 2006; Sfärlea et al., 2016) and visual
inspection of grand averages. The P100 and N170 peak amplitudes
(mean peak amplitudes± 20ms around peak) and peak latencies, as
well as EPN and LPP mean amplitudes, are exported from the averaged
ERPs for all tasks and all emotional categories. The P100 positive peak
amplitude are automatically detected between 80ms and 130ms after
stimulus onset at the left electrode (Electrical Geodesics, Inc. Eugene,
Oregon, 2018), reference (EGR: 65, 69, 70) and right (EGR: 83, 89, 90)
occipital electrode clusters. The N170 negative peak amplitudes are
automatically detected between 140ms and 180ms after stimulus onset
at left (EGR: 50, 57, 58, 64) and right (EGR: 95, 96, 100, 101) parieto-
occipital electrode clusters. The EPN mean amplitudes are measured
from 220ms to 300ms post-stimulus at bilateral parieto-occipital
electrode clusters (left EGR: 58, 59, 65, 69, 70; right EGR: 83, 89, 90,
91, 96).
After examination of grand averages, it was decided to quantify the
LPP in two successive time windows (for a similar approach see
Cuthbert et al., 2000; Solomon et al., 2012). Mean amplitudes of the
LPP will be measured in an early time window from 400ms to 600ms
Table 2
Sequence of events and EEG duration per day during PRISM (note that ﬁrst and
second test day are not consecutive).
Day of
assessment







































MSID: Monetary and Social Incentive Delay; DTI: Diﬀusion Tensor Imaging.
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post-stimulus, as well as in a later time window between 600 and
900ms post-stimulus at a centro-parietal electrode cluster (EGR: 31, 37,
54, 55, 62, 79, 80, 87, 129). Within the EGRs, ERPs from single elec-
trodes will be averaged. All groups should not diﬀer signiﬁcantly in the
number of trials averaged across electrodes within the respective ROIs
for each ERP component and each condition (all p > 0.05). EEG will
be continuously recorded during the test sessions and analyses will be
performed to obtain for each subject, averaged ERPs in response to each
emotion category calculated from the 80 trials. As a basic analysis, four
ERP components will be studied: P100, N170, EPN and LPP. For P100
and N170, peak amplitudes and peak latencies as well as for EPN mean
amplitudes. LPP will be submitted to a similar analysis having shown
reciprocal interactions between occipito-parietal and prefrontal cortices
by using Granger causality, similarly to Moratti et al. (2011).
3. General operational aspects
An identical EEG acquisition system will be employed for all the
testing at the multiple clinical sites. The system includes an EEG am-
pliﬁer and a computerized stimulation module (for visual and auditory
stimuli). Raw data will be recorded using an eego™ sports system
(ampliﬁer and software) from ANT neuro which provides ampliﬁcation,
ﬁltering and sampling of the electrophysiological signal for up to 59
monopolar EEG channels and 2 bipolar EOG used for artefact rejection.
The signal will be digitized on 24 bits. The sampling frequency will be
set at 2048 Hz. Electromagnetic noise due to main power supply will be
removed using a digital narrow 50 Hz centered notch ﬁlter. The EEG
signal will be collected using Waveguard EEG caps from ANTneuro in
which all electrodes are placed according to the International 10-10
electrode placement standard (Waveguard CA-202).
The computerized stimulation module was developed using E-prime
software (Psychology Software Tools, Inc. USA). This module will de-
liver auditory (frequent and odd sounds for the auditory oddball P300,
standard and deviant sounds for MMN, stimulation sound for auditory
steady-state potentials) and visual (frequent and odd geometric ﬁgures
for visual P300, face photographs expressing diﬀerent emotions for
FEP) stimuli. EEG acquisition system and stimulation module are linked
and synchronized with 8-bit trigger input. All EEG data, including the
start and stop times and the impedance check will be recorded digitally.
Evaluation of subjects hearing thresholds will be conducted during
the screening phase using an automated pure tone audiometry test
developed using E-prime. Hearing threshold determination will be
conducted three times by alternatively increasing and decreasing sound
pressures. The headset used (Sennheiser HD 25-1 II) and sound card
(Edirol UA25) were previously calibrated with an artiﬁcial ear (Brüel &
Kjær) and gain value measured on the same sound generator-headset
employed in the study.
To reduce the burden of testing, the protocol is distributed across
three days (screening, ﬁrst day and second day of testing) during which
the sequence of the tests was optimized to limit monotony and sleepi-
ness as well as cognitive load by alternating passive and active tasks.
The content and sequence of tests is described in Table 2.
4. Discussion
Although the approach of PRISM is complex, it reﬂects the hetero-
geneity of psychiatric and neurodegenerative diseases aﬀecting mul-
tiple functions and brain circuitries. It also moves away from the clin-
ical phenomenology to get closer to biolology (Kas et al., 2017). Indeed,
progresses have been made in identifying the clinical features of schi-
zophrenia, starting with acute symptoms, negative symptoms and then
cognitive impairment which have lagged in time and so did therapies.
The multidimensional approach used here is required to identify re-
lationships between symptoms and to identify phenotypes possibly
leading to individualized medicine. Many studies have compared var-
ious biomarkers of endophenotypes between aﬀected and controls,
sometimes relatives, but fewer have used multiple domains such as
fMRI, behavior, scales and electrophysiology. Clementz et al. (2016)
identiﬁed three neurobiologically distinct subtypes of schizophrenia
(biotypes) in a study with 711 individuals with schizophrenia, 883 ﬁrst
degree relatives and 278 subjects combining clinical scoring, ERPs and
voxel-based morphometry with MRI. These biologically distinct phe-
notypes did not respect the clinical boundaries and interestingly, the 3
biotypes had diﬀerent levels of social functioning using the Birchwood
Scale (Birchwood et al., 1990) which varied in an opposite manner
when compared to the Positive and Negative Symptoms Subscale
(PANSS) score. This may be suggestive of a relationship between
biology and social functioning.
The biological substrate of social withdrawal is unclear. As there is
no direct study, it is almost easier to deﬁne what social withdrawal is
not. The overall cognitive impairment is present before the onset of SZ
(Carrión et al., 2018) and in ﬁrst degree relatives of the same age
(Keshavan et al., 2009) progressing over time, while genetic studies
have not identiﬁed one gene mutation but many of them (Smeland and
Andreassen, 2018). Cluster analyses of SZ using clinical scales and
cognitive testing have found evidences of four to ﬁve clusters in an
inconclusive manner (Seaton et al., 2001) or in another study (Ahmed
et al., 2018) three clusters from the pattern of negative symptoms.
There are numerous sensory processing abnormalities which cor-
relate with the clinical diagnosis itself (see Table 1) that are present in
diﬀerent pathologies: SZ (Bilder et al., 2000; Hughes et al., 2003; White
et al., 1997), AD (Reichman et al., 1996; Reichman and Negron, 2001)
and MDD (Galynker et al., 2000; Gerbaldo et al., 1995; Kulhara and
Chadda, 1987). The same reasoning would apply to the study of social
withdrawal by broadening of the study population to distinct disorders
and analyzing the relationships between all parameters and social
withdrawal.
In this study, many biomarkers are obtained using electrophysiology
and some with other methods. In a way, these have already been used
for decades but improvements have either gone using multidimensional
analyses of ERP or advanced analyses of signal-like source localization
for MMN (Tsolaki et al., 2017), connectivity of spontaneous or induced
gamma oscillations (Andreou et al., 2015b) or of any EEG band. Some
authors (Ethridge et al., 2015) combined qEEG with oddball, collecting
N1, P1 and P300. They found two principal components one shared and
one not between 229 schizophrenics, 188 bipolar disorder patients and
284 controls. So, the same approach will be used with more advanced
signal processing and a global approach bridging imaging with elec-
trophysiology, cognitive and behavioral testing therefore learning from
the latest evidences in the heterogeneity of pathologies.
5. Conclusions
The electrophysiologic techniques and sensory processing para-
meters outlined above will allow the proper exploration of the re-
lationship between; social withdrawal, with and across current diag-
nostic classiﬁcation, and the fundamental underlying biology.
Contrasting the subpopulations of high and low social withdrawal may
well point to domains closely associated with sensory processing ab-
normalities alone or interdependent with parameters derived in dif-
ferent areas of measurement elsewhere in the study. This in turn will
allow biomarkers to be identiﬁed and explored that will inform as to
these “construct” diﬀerences that underlie the apparent “face validity”
apparent in the clinical similarities in the dimension of interest, social
withdrawal. Further replications will be necessary to conﬁrm the ro-
bustness of any such novel ﬁndings. Therefore the detailed metho-
dology provided here will ease future comparisons and the replication
in other cohorts and populations of interest. The results of this study
will thus provide the framework with which to expand our under-
standing of what drives social withdrawal in a transnosographic
manner, which so far is terra incognita.
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